secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGIOS PHARMACEUTICALS, INC. (AGIO)
CIK:        0001439222
Form:       8-K
Filed at:   2022-04-26T23:59:59+00:00
Accession:  0001193125-22-120194
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Ian T. Clark resigns from Agios board effective after 2022 annual meeting
--------------------------------------------------------------------------------

- Ian T. Clark resigns as director effective immediately following the 2022 annual meeting.
- Clark also steps down from Compensation & People and Nominating & Corporate Governance committees.
- Company states resignation not related to any disagreement over operations, policies, or practices.
- No replacement director announced as of April 25, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1439222/000119312522120194/0001193125-22-120194-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1439222/000119312522120194/d335110d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-120194

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer